The FTC is not anti-direct selling. It’s pro-truth in advertising.
The DSA misses the mark.
In October 2019, a class-action lawsuit was filed against Protalus for allegedly misleadingly marketing that Protalus Insoles are guaranteed to provide lasting pain relief from a variety of injuries and conditions – including neuropathy, plantar fasciitis, back pain, heel spurs, diabetic foot, high arches, blisters, heel pain, hammer toes, and swelling – when, according to plaintiffs, the insoles do not provide the advertised benefits. (Saitta et al v. Protalus, LLC et al, Case No. 19-cv-12156, D. MA.)
The DSA misses the mark.
TINA.org reader takes issue with this product’s deceptive packaging.
Don’t let this company blindside you with its deceptive pricing.
Lawsuit pokes holes in company’s Swiss branding.
Why are these airport vendors slyly charging consumers for “employee benefits”?